Suven Life Sciences Limited

Web: suven.com NSE: SUVEN BSE: 530239 SECTOR: Healthcare - Healthcare Services

278 7(3%)

Near 52W High of 300

Volume

Open

132

High

138

Low

131

271

VWAP

52 Week High

300

52 Week Low

120

Viand Research Rating

Quality Score

00/00

Growth Score

00/00

Valuation Score

00/00

Momentum Score

00/00

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

7,331

No. of Shares

26.4

P/E

-104.53

P/B

3.29

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

-3.15

ROCE

Profit Growth

Listing Date

23-Oct-03

Promoter Holding

70.15%

FII Holding

0.91%

DII Holding

4.62%

Price Chart

Price Performance

1 Week0

1 Month0

3 Months0

6 Months0

1 Year0

YTD0

Moving Average

5 Day SMA0

10 Day SMA0

20 Day SMA0

30 Day SMA0

50 Day SMA0

61 Day SMA0

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3
Resistance 2
Resistance 1
Pivot Point
Support 1
Support 2
Support 3

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	Div Yld %
1	SUNPHARMA	4,42,187	1843	2%	14%	2%	9%	39	0	0	0
2	DIVISLAB	1,80,280	6791	2%	6%	4%	1%	65	0	0	0
3	TORNTPHARM	1,53,281	4529	0%	8%	18%	40%	64	0	0	0
4	APOLLOHOSP	1,19,047	8280	3%	7%	12%	17%	58	0	0	0
5	CIPLA	1,14,869	1422	1%	10%	7%	4%	22	0	0	0
6	DRREDDY	1,11,015	1330	0%	1%	7%	7%	20	0	0	0
7	ZYDUSLIFE	1,09,378	1087	6%	16%	15%	17%	20	0	0	0
8	LUPIN	1,04,017	2275	1%	2%	9%	15%	23	0	0	0
9	MANKIND	1,00,482	2434	3%	7%	7%	2%	49	0	0	0
10	MAXHEALTH	96,867	995	7%	1%	15%	14%	0	0	0	0
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jul 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(2.81) 70.15%	(0.01) 67.36%	(-0.11) 67.36%	(-2.81) 67.42%	(0.01) 70.26%	(0.01) 70.26%	(0.01) 70.26%	(0.01) 70.26%	(0.71) 70.26%	(0.01) 69.56%	(0.01) 69.56%	(0.01) 69.56%	(0.01) 69.56%	(0.01) 69.56%	(4.61) 69.56%	(0.01) 64.98%	(0.01) 64.98%	(5.01) 64.98%	(0.01) 60.00%	(0.01) 60.00%
FIIs	(-0.21) 0.91%	(-0.11) 1.07%	(0.61) 1.17%	(0.01) 0.56%	(0.31) 0.58%	(-0.11) 0.25%	(0.01) 0.34%	(-0.11) 0.33%	(0.01) 0.45%	(-0.11) 0.46%	(0.01) 0.54%	(0.01) 0.50%	(0.01) 0.48%	(0.11) 0.51%	(0.01) 0.46%	(0.01) 0.48%	(0.01) 0.45%	(-0.11) 0.45%	(0.11) 0.52%	(0.01) 0.44%
DIIs	(1.21) 4.62%	(0.01) 3.39%	(0.01) 3.39%	(3.41) 3.41%	(0.01) 0.03%	(-1.01) 0.01%	(0.01) 1.05%	(0.01) 1.05%	(0.01) 1.05%	(1.01) 1.05%	(0.01) 0.01%	(-0.11) 0.01%	(0.01) 0.08%	(0.01) 0.11%	(0.01) 0.11%	(-0.31) 0.12%	(-0.11) 0.39%	(0.01) 0.46%	(0.01) 0.44%	(0.01) 0.44%
Public	24.32%	28.18%	28.07%	28.61%	29.12%	29.47%	28.35%	28.34%	28.21%	28.91%	29.88%	29.92%	29.88%	29.80%	29.85%	34.41%	34.18%	34.11%	39.04%	39.12%
No. of Shareholders	63,915	64,381	64,921	65,574	66,159	64,603	63,537	63,975	66,116	68,959	74,003	80,953	76,291	78,634	80,838	80,116	81,038	81,039	80,195	81,475

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	2	3	1	2	1	2	3	1	2	2	3	4	3	3	4	4	4	4	1	2
Expenses	52	106	81	53	45	41	55	32	33	49	27	32	34	55	26	25	24	37	29	45
Operating Profit	-51	-103	-80	-51	-44	-39	-52	-31	-30	-46	-24	-28	-32	-52	-22	-21	-20	-32	-28	-43
OPM %	-3331	-3678	-8671	-2714	-2981	-2435	-2032	-3024	-1267	-1885	-768	-737	-1208	-1719	-494	-596	-467	-733	-2340	-2118
Other Income	7	3	4	1	1	2	4	4	4	6	13	6	6	2	0	6	0	0	0	5
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	2	1	1	1	1	2	1	1	2	2	2	2	2	2	2	2	1	1	1	1
Profit before tax	-46	-102	-77	-52	-44	-39	-50	-28	-28	-42	-13	-24	-28	-51	-23	-16	-21	-34	-28	-39
Tax %	0	0	0	0	0	0	0	0	-4	0	0	0	0	0	0	0	0	0	0	0
Net Profit	-46	-102	-77	-52	-44	-39	-50	-28	-27	-42	-13	-24	-28	-51	-23	-16	-21	-34	-28	-39
EPS in Rs	-1.73	-4.48	-3.4	-2.36	-2.01	-1.79	-2.28	-1.29	-1.22	-1.91	-0.58	-1.1	-1.27	-2.34	-1.06	-0.75	-0.95	-1.76	-1.48	-2.05

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2008	Mar 2007
Sales	7	7	12	14	12	13	13	286	625	543	499	521	117	112
Expenses	292	172	140	139	134	93	128	300	427	414	398	361	105	96
Operating Profit	-284	-166	-128	-126	-122	-80	-116	-14	198	129	102	159	13	16
OPM %	-4001	-2487	-1094	-929	-1032	-593	-917	-5	32	24	20	31	11	15
Other Income	14	11	29	14	5	8	14	27	23	21	19	9	3	1
Interest	0	0	0	0	1	1	1	2	5	6	6	5	5	3
Depreciation	6	6	6	7	4	4	4	11	21	21	18	12	4	4
Profit before tax	-276	-161	-106	-118	-122	-77	-106	0	196	123	98	152	6	11
Tax %	0	0	-1	0	0	-7	-11	15038	37	29	26	28	-32	-5
Net Profit	-276	-161	-105	-118	-122	-72	-94	-24	124	87	72	109	8	11
EPS in Rs	-10.48	-7.37	-4.82	-5.42	-5.59	-3.78	-4.94	-1.25	6.48	4.57	3.76	5.7	0.48	0.65
Dividend Payout %	0	0	0	0	0	0	0	-80	15	15	35	7	35	26

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2008	Mar 2007
Cash from Operating Activity	-302	-154	-115	-116	-128	-96	-135	-53	70	109	68	143	4	16
Cash from Investing Activity	-462	155	94	-248	-22	56	146	30	-1	-311	-39	-110	-16	-20
Cash from Financing Activity	757	-1	-1	396	146	35	3	5	-52	-30	-68	179	6	13
Net Cash Flow	-7	0	-22	32	-4	-5	14	-18	17	-232	-39	212	-7	8

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2008	Mar 2007
Equity Capital	26	23	22	22	22	22	15	13	13	13	13	13	13	13	12	6
Reserves	565	259	88	171	248	354	82	95	131	226	755	654	583	547	95	96
Borrowings	17	0	0	0	1	2	3	5	6	3	34	71	83	109	55	41
Other Liabilities	16	56	25	19	14	12	9	16	33	62	118	78	74	105	38	30
Total Liabilities	624	337	135	212	285	389	108	128	182	303	919	816	751	773	199	173
Fixed Assets	73	58	60	25	28	37	38	21	25	22	308	306	305	172	110	96
CWIP	4	1	0	0	0	0	4	5	0	0	25	10	7	107	4	5
Investments	181	247	22	74	76	46	45	0	0	223	279	301	0	0	2	5
Other Assets	367	32	53	113	181	305	22	103	157	58	308	199	439	494	83	68
Total Assets	624	337	135	212	285	389	108	128	182	303	919	816	751	773	199	173

Delivery

#	Date	124 138% 295	Value (Cr)	Q/T 82	Del 34	Del 24
1	27-May	267	21	45	37	8
2	26-May	274	80	59	26	21
3	25-May	271	23	47	30	7
4	22-May	265	21	47	32	7
5	21-May	270	32	58	20	6
6	20-May	269	83	66	15	12
7	19-May	269	434	71	7	32
8	18-May	253	416	89	11	47
9	15-May	211	11	40	37	4
10	14-May	207	8	41	52	4
11	13-May	210	9	48	43	4
12	12-May	216	10	47	36	3
13	11-May	218	6	52	54	3
14	8-May	223	9	49	60	5
15	7-May	220	6	40	45	3
16	6-May	214	10	45	53	5
17	5-May	206	9	46	45	4
18	4-May	212	3	32	42	1
19	30-Apr	212	5	42	51	3
20	29-Apr	217	8	62	50	4
21	28-Apr	219	23	98	49	11
22	27-Apr	212	14	76	49	7
23	24-Apr	202	6	80	47	3
24	23-Apr	208	7	77	50	3
25	22-Apr	213	6	67	52	3
26	21-Apr	210	10	78	52	5
27	20-Apr	210	29	93	34	10
28	17-Apr	196	9	77	46	4
29	16-Apr	196	9	91	44	4
30	15-Apr	192	7	87	51	4
31	13-Apr	190	9	82	48	4
32	10-Apr	196	44	86	29	13
33	9-Apr	178	13	84	46	6
34	8-Apr	169	7	86	56	4
35	7-Apr	167	9	70	40	4
36	6-Apr	168	19	84	41	8
37	2-Apr	158	17	81	30	5
38	1-Apr	147	13	90	30	4
39	30-Mar	132	27	121	35	10
40	27-Mar	130	9	131	58	6
41	25-Mar	134	7	99	48	3
42	24-Mar	129	6	83	53	3
43	23-Mar	127	5	86	56	3
44	20-Mar	134	4	100	56	2

Daily Market Cap

Date	Total Market Cap	Change	Chg %
26-May	7,331c	184c	2.58
25-May	7,147c	77c	1.09
22-May	7,070c	108c	1.51
21-May	7,179c	85c	1.19
20-May	7,094c	79c	1.10
19-May	7,173c	923c	14.77
18-May	6,250c	668c	11.96
15-May	5,582c	150c	2.75
14-May	5,433c	79c	1.43
13-May	5,512c	108c	1.92
12-May	5,620c	103c	1.80
11-May	5,723c	92c	1.59
07-May	5,815c	140c	2.46
06-May	5,675c	245c	4.52
05-May	5,430c	259c	4.55
04-May	5,689c	80c	1.42
30-Apr	5,609c	107c	1.88
29-Apr	5,716c	80c	1.39
28-Apr	5,797c	394c	7.30
24-Apr	5,402c	168c	3.02
23-Apr	5,571c	49c	0.88
22-Apr	5,620c	135c	2.45
21-Apr	5,485c	0	0
20-Apr	5,485c	343c	6.67
17-Apr	5,143c	81c	1.60
15-Apr	5,062c	0	0

Stock Checklist

Price is above from 52 week high low average: 76%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: NO

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: YES

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView